生命科学资讯

Norgine gets in on Vir's hepatitis D program with €550 European licensing pact

Fired NIH institute director sues Trump health officials, seeks reinstatement and backpay

Vistagen phase 3 study sees placebo surprise, putting future of social anxiety asset into question: analyst

Will Lonza Group AG (Common Stock) (LO3A) stock gain from green policies - Weekly Gains Summary & Technical Confirmation Alerts - Bollywood Helpline

European Commission unveils EU Biotech Act as it lags behind other countries

Senate passes Biosecure Act aimed at Chinese suppliers

RFK Jr. adds conditions to newborn screening list after committee termination

CDC stops recommending universal hepatitis B birthdose

Several companies expected to announce ‘most favored nation’ deals Friday at White House

FDA clears GSK’s twice-yearly asthma drug

FDA eyes less restrictive approach to RWE in regulatory decisions

Appointments and advancements for Dec. 17, 2025

Financings for Dec. 17, 2025

Other news to note for Dec. 17, 2025

Regulatory actions for Dec. 17, 2025

Illumina Target of Unusually Large Options Trading (NASDAQ:ILMN) - MarketBeat

Peanut allergy patch succeeds in late-stage study 5 years after FDA rejection

Addition Tx does the math and emerges from stealth with $100M, biotech vets on exec team

Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B

Medtronic rolls out new peripheral thrombectomy system while making advances in brain bleeds